Global DNA Markers Market, By Product (Below 50 Bp, 50 Bp To 100 Bp, 100 Bp To 1 Kb, 1 Kb To 5 Kb, Above 5 Kb), Type (Prestained Markers, Unstained Markers, Specialty Markers), Application (Nucleic Acid Applications, Proteomics Applications), End Users (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, CROs, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Get Exclusive Sample Copy of this Report Here
Market Analysis and Insights : Global DNA Markers Market
DNA markers market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 10.91% in the forecast period of 2021 to 2028 and is expected to reach USD 283.20 million by 2028. The growth in popularity of personalized medicine for the treatment of genetic disorders and chronic diseases is escalating the growth of DNA markers market.
DNA markers refer to a DNA sequence or gene with a known location on a chromosome and related to a certain gene or trait. Genetic elements such as DNA sequence or chromosome feature, locus and allele which can be easily detected or identified by cytological or molecular techniques and phenotype and follows chromosomal segment or chromosome during genetic analysis is known as a marker.
The rise in the adoption rate of personalized medicine among population globally and increase in the emphasis on molecular biology research activities are major factors driving the DNA markers market. The demand is also influenced by the increase in technical advances in molecular biology products, including PCR and NGS, coupled with high-quality molecular weight markers. The increase in the investment and funding in research and development programs by biotechnology companies and pharmaceutical companies and rise in funding in life science research by public organizations positively affect the market. New innovations in genomics and proteomics research projects accelerate the market growth. Additionally, the growing collaborations among academic, pharmaceutical and biotechnology companies for molecular research also act as driving factors for DNA markers market. Furthermore, emergence of untapped markets extends profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high installation cost, complexity of the procedure and high degree of consolidation for new firms are factors expected to obstruct the market growth. Concerns regarding the standardization and lack of skilled workforce are projected to challenge the DNA markers market.
This DNA markers market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on DNA markers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
DNA Markers Market Scope and Market Size
DNA markers market is segmented on the basis of product, type, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the DNA markers market is segmented into below 50 bp, 50 bp to 100 bp, 100 bp to 1 kb, 1 kb to 5 kb and above 5 kb.
- On the basis of type, the DNA markers market is segmented into prestained markers, unstained markers and specialty markers.
- On the basis of application, the DNA markers market is segmented into nucleic acid applications and proteomics applications. Nucleic acid applications are further segmented into PCR, sequencing, northern blotting, southern blotting, molecular cloning and others. Proteomics applications are further segmented into western blotting, gel extraction and others.
- On the basis of end users, the DNA markers market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, CROs and others.
Global DNA Markers Market Country Level Analysis
DNA markers market is analyzed and market size insights and trends are provided by country, product type, application and end users as referenced above.
The countries covered in the DNA markers market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the DNA markers market because of the developed healthcare and research infrastructure and presence of large biotechnology firms and research laboratories. Asia Pacific is expected to witness highest CAGR in the forecast period of 2021-2028 because of the growth in CROs and biotechnology companies, less stringent regulations regarding clinical trials and availability of skilled workforce in this region.
The country section of the DNA markers market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
DNA markers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for DNA markers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the DNA markers market. The data is available for historic period 2010 to 2019.
Competitive Landscape and DNA Markers Market Share Analysis
DNA markers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to DNA markers market.
The major players covered in the DNA markers market report are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biogen, Illumina, Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific, New England Biolabs., Promega Corporation., Affymetrix microarray solutions, QIAGEN, Takara Bio Inc., Abcam plc., Aline Biosciences, Arc Bio, LLC., MicroGen Diagnostics., Phalanx Biotech Group., Quantum Biosystems, Trace Genomics, Inc., ALLSEQ, INC., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-